Popular weight-loss drugs face numerous lawsuits over rare ‘eye stroke’ linked to vision loss

Hundreds of consumers are suing the manufacturers of GLP-1 receptor agonists, alleging the medications may increase the risk of a rare form of vision loss.

The patients behind the lawsuits allege that the medications caused NAION (nonarteritic anterior ischemic optic neuropathy), according to The Wall Street Journal.

NAION is a rare eye condition in which blood flow to the optic nerve is suddenly reduced, leading to sudden vision loss.

POPULAR GLP-1 WEIGHT-LOSS DRUGS LINKED TO...